ATLAS fair value
ATLAS has no fair value for this stock today.
Medical Facilities stock price today, ATLAS forecast and fair value
Healthcare · Medical Care Facilities · Toronto Stock Exchange · Canada
Prices as of Oct 27, 2026 · CAD
ATLAS has no fair value for this stock today.
52%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS's model gives Medical Facilities a 52% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between CA$14.06 and CA$15.32; in 9 out of 10, between CA$13.03 and CA$16.53. Estimated annual volatility is 25%.
ATLAS does not publish a fair value for DR.TO right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks DR.TO has traded between CA$13.59 and CA$18.79. Today it is 22.1% below that high and 8% above its low.
On the business: net margin is 14.6%; it trades at 15.0 times earnings.
Its beta is 0.35: it tends to move less than the market.
Medical Facilities Corporation, through its subsidiaries, owns and operates specialty surgical hospitals in the United States.
Want to see everything about Medical Facilities?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
Medical Facilities Corporation, through its subsidiaries, owns and operates specialty surgical hospitals in the United States.
52%: close to a coin flip. In half of the simulated outcomes, DR.TO ends the month between CA$14.06 and CA$15.32.
Medical Facilities's market capitalization is CA$234M. Its price-to-earnings (P/E) ratio is 15.0: you pay CA$15.0 for each CA$1.00 of yearly earnings.
Yes. DR.TO's current dividend yield is 1.76% at today's price (CA$14.63).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy